A5HZZ6 (A5HZZ6_CLOBH) Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A)
Hemagglutinin component of the neurotoxin complex UniProtKBAFDB90v4InterProInteractive Modelling
293 aa; Sequence (Fasta) ;
1 identical sequence: Clostridium botulinum: Q45871
It is possible new templates exist for this target since these models were created.
Available Structures
9 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Apo HA17-HA33 |
Heteromer Q45871; Q45878; | |||||
| Assess | ||||||
| Crystal structure of HA17-HA33-IPT |
Heteromer Q45871; Q45878; | 2×IPT; | ||||
| Assess | ||||||
| HA17-HA33-LacNac |
Heteromer Q45871; Q45878; | 2×NDG; | ||||
| Assess | ||||||
| HA17-HA33-Lac |
Heteromer Q45871; Q45878; | 2×BGC; | ||||
| Assess | ||||||
| HA17-HA33-Gal |
Heteromer Q45871; Q45878; | 2×GAL; | ||||
| Assess | ||||||
| Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex |
Heteromer A5HZZ4; A5HZZ5; P09803; | 3×CA; | ||||
| Assess | ||||||
| HA70(D3)-HA17-HA33 |
Heteromer Q45871; Q45878; Q8KHU9; | |||||
| Assess | ||||||
| Crystal structure of HA17-HA33-Lactulose |
Heteromer Q45871; Q45878; | 2×FRU; | ||||
| Assess | ||||||
| Crystal structure of HA33A, a neurotoxin-associated protein from Clostridium botulinum type A | monomer | |||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4qd2.2.A | monomer | 0.89 | 100.00 | |||
| Assess | ||||||
| 5fv9.3.A | homo-2-mer | 0.56 | 19.10 | |||
| Assess | ||||||